Curis (CRIS) Total Current Liabilities (2010 - 2026)
Curis' (CRIS) quarterly Total Current Liabilities came in at $15.0 million in Q1 2026, down 25.57% YoY from $20.1 million in Q1 2025, and up 6.38% on a QoQ basis from $14.1 million in Q4 2025.
Curis (CRIS) Total Current Liabilities (2010 - 2026) Analysis & Trends
Curis (CRIS) has 17 years of Total Current Liabilities data on file, last reported at $15.0 million in Q1 2026.
- Quarterly Total Current Liabilities fell 25.57% year-over-year to $15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.0 million (down 25.57% YoY) and the FY2025 annual result came in at $14.1 million, down 26.02% from the prior year.
- Total Current Liabilities rose to $15.0 million in Q1 2026, from $14.1 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $22.0 million in Q3 2024 to a low of $8.1 million in Q1 2023.
- A 5-year average of $15.3 million and a median of $14.1 million in 2025 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Current Liabilities surged 119.92% — and 2025, when it declined 26.02%.
- Tracing CRIS's Total Current Liabilities over 5 years: stood at $10.0 million in 2022, then surged by 119.92% to $22.0 million in 2023, then declined by 13.6% to $19.0 million in 2024, then dropped by 26.02% to $14.1 million in 2025, then grew by 6.38% to $15.0 million in 2026.
- The last three Total Current Liabilities figures came in at $15.0 million (Q1 2026), $14.1 million (Q4 2025), and $19.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 630.93 Mn |
| 10 | Curis | 3.48 Mn | -2.14 Mn | - | 13.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.97 Mn |
| Dec 31, 2025 | 14.08 Mn |
| Sep 30, 2025 | 19.91 Mn |
| Jun 30, 2025 | 19.37 Mn |
| Mar 31, 2025 | 20.12 Mn |
| Dec 31, 2024 | 19.03 Mn |
| Sep 30, 2024 | 22.03 Mn |
| Jun 30, 2024 | 19.37 Mn |
| Mar 31, 2024 | 11.30 Mn |
| Dec 31, 2023 | 22.02 Mn |
| Sep 30, 2023 | 13.71 Mn |
| Jun 30, 2023 | 9.68 Mn |
| Mar 31, 2023 | 8.07 Mn |
| Dec 31, 2022 | 10.01 Mn |
| Sep 30, 2022 | 13.74 Mn |
| Jun 30, 2022 | 12.15 Mn |
| Mar 31, 2022 | 9.69 Mn |
| Dec 31, 2021 | 13.44 Mn |
| Sep 30, 2021 | 9.47 Mn |
| Jun 30, 2021 | 7.87 Mn |